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ABSTRACT 
Multivesicular bodies (MVBs) are endocytic compartments that contain intraluminal vesicles formed by 
inward budding from the limiting membrane of endosomes. In T lymphocytes these vesicles contain pro-
apoptotic Fas ligand (FasL), that may be secreted as “lethal exosomes” upon fusion of MVBs with the 
plasma membrane. Diacylglycerol kinase α (DGKα) regulates the secretion of exosomes, but it is unclear 
how this control is mediated. T lymphocyte activation increases the number of MVBs that contain FasL. 
DGKα is recruited to MVBs and exosomes where it has a double function. DGKα kinase activity exerts 
a negative role in the formation of mature MVBs as we demonstrate by the use of an inhibitor. 
Downmodulation of DGKα protein resulted in inhibition of both the polarization of MVBs towards 
immune synapse and exosome secretion. The subcellular location of DGKα together with its complex 
role in the formation and polarized traffic of MVBs support the notion that DGKα is a key regulator of 
the polarized secretion of exosomes. 
KEYWORDS: T lymphocytes/Diacylglycerol kinase α/Multivesicular bodies/Fas ligand/ exosomes/ 
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INTRODUCTION   
Exosomes are small membrane vesicles of endocytic origin that are secreted by many cells. 
These vesicles are formed by inward budding of the limiting membrane of late endosomes, and 
accumulate as intraluminal vesicles (ILVs) inside multivesicular bodies (MVBs)1. Stimulation of cells 
induces the fusion of the limiting membrane of the MVBs with the plasma membrane (PM) and the 
secretion of the ILVs, which then are termed exosomes1.  
Cytotoxic T lymphocytes (CTLs) use both perforin/granzyme and Fas ligand (FasL)-dependent 
pathways to exert their function. Regarding FasL, CTLs kill Fas+ cells by exposing pre-formed FasL on 
the PM at the immunological synapse2. FasL induces cross-linking of the Fas death receptor on the target 
cell and apoptosis3. In CTLs, FasL is located at the limiting membrane of secretory lysosomes containing 
perforin/granzyme, with MVB structure2. Upon T cell receptor activation (TCR), MVBs undergo fusion 
with the PM and re-localisation of FasL to the PM occurs2.  
In addition to this transport of FasL, another mechanism for the delivery of FasL co-exists in 
CTLs4. This mechanism is due to the fact that FasL can be sorted from the limiting membrane of the 
MVBs to the ILVs via inward budding4,5. Upon cell activation, the fusion of pre-existing MVBs with the 
PM results in the release of exosomes containing FasL5. In certain cells such as Jurkat6 or melanoma 
cells7, this ILVs/MVBs pathway is the main mechanism involved in FasL traffic. Accordingly, a 
difference exists in FasL traffic between CTLs and non-CTLs cells as Jurkat. Although in both cell types 
pre-formed and activation-induced synthesis of FasL coexist, in Jurkat cells the majority of FasL 
undergoes sorting to the ILVs in MVBs and is secreted into exosomes5. In addition, no PM relocation of 
FasL was observed in Jurkat5, J-HM1-2.28 or melanoma cells7, even in the presence of metalloproteinase 
inhibitors to avoid shedding of FasL from the cell surface9. This supports that, in contrast to FasL found 
in CTLs2, in Jurkat cells none or very little FasL is located in the limiting membrane of the MVBs. 
 Previous results have shown the role of diacylglycerol kinase α (DGKα), a diacylglycerol 
(DAG)–consuming enzyme10, on activation11 and activation-induced cell death (AICD) of T 
lymphocytes8. AICD was defined as an autocrine suicide triggered by T cell receptor  (TCR) stimulation, 
which controls lymphocyte homeostasis12, that can be mimicked by muscarinic type 1 receptor (HM1R) 
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stimulation with carbachol (CCh) in J-HM1-2.2 cells13. AICD requires de novo synthesis of FasL12 and its 
secretion into exosomes6,8. Consequently, the kinetics for apoptosis initiation during AICD is slow (> 4-5 
h) when compared to CTL-mediated cytotoxicity, which occurs in minutes. The inhibition of DGKα 
kinase activity increased the secretion of exosomes bearing FasL that was induced upon activation 
through TCR or the HM1R, a model for AICD8,13. Subsequently, the enhanced secretion of exosomes led 
to an increase in FasL-dependent AICD8.  These results support that the effect of DGKα on apoptosis 
occurs by regulating the release of exosomes bearing de novo synthesized FasL8. However, from these 
studies it was not clear whether stimulation of T lymphocytes affects the traffic of MVBs. In addition, the 
regulatory point(s) on secretory traffic of exosomes controlled by DGKα  remained obscure. 
Secretory vesicular traffic involves several checkpoints controlled by DAG at which cellular 
stimulation and DGKα might act. These include the fission of vesicles at the trans-Golgi network (TGN), 
the generation and maturation of MVBs (i.e., number of MVBs per cell and inward vesiculation within 
MVB), the transport of the MVBs, and their docking and fusion to the PM14-17. To explore these 
possibilities we have used pharmacological and genetic approaches.  
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 RESULTS 
T lymphocyte activation increases the formation of mature MVBs containing FasL. 
Stimulation of TCR or HM1R in J-HM1-2.2 cells induces apoptosis13, that occurs via the release 
of exosomes containing CD63 and de novo-synthesised FasL8. To explore the mechanisms involved in 
exosome secretion, we analysed the MVB markers CD63, Lamp-1 and the lipid lysobisphosphatidic acid 
(LBPA) in CCh-stimulated cells. Immunofluorescence analysis of CD63, FasL and LBPA showed that 
these markers were located in vesicles (Fig. 1A). Comparable results were obtained in cells expressing 
CFP-CD63 (Fig. 1B). The stimulation enhanced the number of CD63+, FasL+ or LBPA+ vesicles (Fig. 
1A). To confirm this, a quantitative analysis was performed by flow cytometry and WB. As shown in 
Suppl. Fig. S1, CCh increased the fluorescence of cells stained with anti-CD63, FasL or LBPA. The 
subcellular fractionation on Percoll gradients has been used to analyze FasL into secretory lysosomes 
from CTLs2 and MVBs from T lymphocytes8. The gradient from non-stimulated cells showed that CD63+ 
and Lamp-1+ fractions 12 and 13, which had the density of MVBs (ρ=1.05−1.06  g/ml)8,18, contained 
some pre-existing FasL (Fig. 2). Stimulation with CCh for 6 hours, which up-regulate the levels of FasL 
mRNA13 and protein (Suppl. Fig. S1), enhanced dramatically the amount of FasL and CD63 in the 
fractions corresponding to MVBs (12-13) (Fig. 2). Thus, cellular stimulation induces the recruitment of 
the upregulated Fas ligand to subcellular compartments migrating at the same density that MVBs 
Taken together, these results may represent an increase in the formation of mature MVBs upon 
cell activation. To analyse this, but also to stress whether the molecules found in the same fractions were 
present in the MVBs, we carried out analysis of LBPA in cells expressing CFP-CD63. LBPA constitutes 
a bona fide marker for ILVs of mature MVBs. As shown in Fig. 1B, LBPA co-localised with CD63, and 
stimulation with CCh increased the number of LBPA+/CD63+ vesicles (Suppl. Fig. S2). Thus, the 
biochemical and immunofluorescence results, together the published results showing colocalisation of 
FasL with CD63 and lamp-15 supported that, upon CCh stimulation, there was an increase in the number 
of mature MVBs containing CD63, LBPA, and FasL.  
To confirm these vesicles exhibited MVBs ultra-structure, we analysed cells by electron 
microscopy. As shown in Suppl. Fig. S3, stimulation with CCh increased the number of vesicles 
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containing an electron-dense content with the features of MVBs observed in CTLs19 and T lymphocytes5. 
Taken together, the data support that stimulation of cells increased the number of mature MVBs that 
contain FasL. We examined next the contribution of DGKα to the biogenesis of MVBs and exosomes.  
Inhibition of DGKα  kinase activity increases the number of mature MVBs  
Fractionation on Percoll gradients has revealed the presence of DGKα in CD63+ late endosome 
fractions from non-stimulated cells20. Similar analysis following CCh treament revealed that the increase 
in DGKα levels in these fractions mirrored those of CD63 and FasL, suggesting that stimulation 
enhances the formation of DGKα-enriched MVBs (Fig. 2). We have shown that inhibition of DGKα 
kinase activity increased exosome release8. As CCh enhances association of DGKα with subcellular 
fractions containing MVBs, we analysed the influence of DGKα kinase activity on the formation of 
MVBs upon stimulation. Treatment of the cells with the inhibitor of type I DGKs R5994921 enhanced the 
number of exosomes secreted in non-stimulating conditions as determined by FACS; this effect was 
stronger in response to CCh (from 6481 up to 9410 events) (Fig. 3A). DGKα inhibition resulted in higher 
levels of CD63 and its redistribution in fractions containing MVBs (Fig. 3B), and enhanced the ability of 
CCh to increase the number of vesicles decorated with CD63 and the number of LBPA+ vesicles (Suppl. 
Fig. S4). The vesicles induced by CCh in the presence of R59949 displayed the features of MVBs 
(Suppl. Fig. S3) and contained both CFP-CD63 and LBPA (not shown). Together, these data indicate that 
the inhibition of DGKα kinase activity enhances the formation of CD63+, LBPA+ mature MVBs, which 
correlates with the enhanced release of exosomes. 
Inactive DGKα  co-localizes with MVBs  
The previous experiments demonstrate that DGKα is found in subcellular fractions containing 
MVBs, and suggest a negative function of DGKα  kinase activity in the formation of mature MVBs. If 
this is the case, then DGKα may be found associated with the limiting membrane of MVBs, sorted to the 
ILVs and then secreted in exosomes. We have demonstrated that DGKα localization is negatively 
regulated by its own kinase activity, since R59949 enhances association of DGKα to membranes11. 
Therefore, we used confocal microscopy to investigate the effect of the inhibition of DGKα kinase 
activity on DGKα localization. CCh in the presence of R59949 induced, in addition to the described 
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translocation of GFP-DGKα to the PM11, the accumulation of GFP-DGKα in vesicles, most of them 
CD63+, distributed throughout the cytoplasm (Fig. 4A and 4B, arrows). Since R59949 enhanced the 
release of exosomes8 and induced the formation of mature (CD63+ LBPA+) MVBs (Suppl. Fig. S4), we 
analysed by WB the exosomes secreted from cells stimulated with CCh, in the presence or the absence of 
R59949, for the presence of DGKα. As shown in Fig. 4C, the amount of DGKα secreted in the exosomes 
mirrored the increase corresponding to other proteins (i.e. CD63) or inducible FasL (compare CCh 500 
vs CCh 500 plus R59949) .  
Traffic of MVBs  
To analyse the contribution to exosome secretion of the transport and fusion of MVBs to the PM, 
and to assess the effect of DGKα on these events, we analysed the traffic of MVBs. To this end, we used 
expression vectors for the MVB/exosome marker CD63 fused to GFP, DsRed2 or CFP. As shown in Fig. 
5A, CCh enhanced the amount of GFP-CD63+ and DsRed2-CD63+ exosomes secreted by transfected 
cells, as seen with endogenous CD63 (Fig. 4C). Once the reporters were validated, we analysed the 
formation and traffic of MVBs containing the reporters in living cells. The expression of GFP-CD63 in 
non-stimulated cells revealed vesicles distributed all over the cytoplasm, and the PM was weakly stained 
with GFP-CD63 (Fig 5B, upper panels). Time-lapse microscopy showed a myriad of CFP-CD63+ 
vesicles undergoing a rapid movement inside the cytoplasm (Supplementary Videos 1 and 2). Particularly 
upon CCh stimulation, these vesicles exhibited bidirectional motion emerging from the pericentriolar 
area. Stimulation with CCh for 24h increased the intensity of the labelling, the number of these granules 
and their dispersion within the cell (Fig. 5B, videos 1 and 2). In addition, stimulation for 6h enhanced the 
staining of GFP-CD63 at the PM (Fig. 5B). Some of the scattered granules appeared as ring-shaped 
vesicles (Supplementary video 4, zoom in Fig. 5B), brightly labelled with the chimera at the peripheral 
membrane. Time-lapse microscopy showed that, upon stimulation, some vesicles approached, seemed to 
dock to the PM and disappeared (Supplementary Videos 3, 4); these observations are compatible with the 
fusion of the MVBs to PM.  
Next, we studied the role of DGKα pathway on the formation and fate of MVBs. R59949 
enhanced the fluorescence of the intracellular vesicles and the accumulation of GFP-CD63 in the PM 
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upon CCh stimulation for 6 h (Fig. 5B). The CCh and R59949-induced increase in GFP-CD63 at the PM,  
was due to the fusion of the limiting membrane of GFP-CD63+ MVBs (Videos 3 and 4). This, combined 
with the increased number of CD63+ and LBPA+ vesicles which was induced by CCh and R59949 (Figs. 
1, 3, and Suppl. Figs. S2 and S4) and the enhanced secretion of GFP-CD63+ exosomes (Fig. 5A), support 
that the inhibition of the kinase activity of DGKα increases the formation of mature MVBs containing 
intraluminal, CD63+/LBPA+ vesicles. In addition, as shown in overexposed blots (Fig. 5A), R59949 
enhanced the constitutive secretion of exosomes containing GFP-CD63 as previously reported with 
endogenous CD638.      
Overexpression of DGKα  inhibits the formation of mature MVBs  
If the effect of R59949 is exerted via the inhibition of DGKα kinase activity, it would be 
expected that overexpression of the enzyme would decrease the number of mature MVBs, leading to a 
reduction in exosome secretion8,20. To study the number of mature MVBs we analysed the distribution of 
CD63 and LBPA in cells co-transfected with CFP-CD63 and GFP-DGKα,  GFP-VPS4wt, and GFP-
VPS4EQ. The expression of a VPS4 ATPase-defective mutant, VPS4EQ, constitutes a control for 
aberrant MVBs maturation22,23. As shown in Fig. 6, GFP-VPS4wt was cytosolic, whereas VPS4EQ 
accumulated in a few, bright-fluorescent foci that co-localized with CFP-CD63 and LBPA (Fig. 6 and 
Suppl. Fig. S5), with the appearance of enlarged, ring-shaped vesicles. There was a reduction in the 
number of LBPA+ vesicles in GFP-VPS4EQ+ cells when compared with non-transfected cells or GFP-
VPS4wt+ cells (Fig. 6). CCh stimulation of non-transfected cells or GFP-VPS4wt+ cells increased the 
number and the labelling of the LBPA+ vesicles. By contrast, upon stimulation of GFP-VPS4EQ+ cells, 
the number of LBPA+ vesicles remained low and few, enlarged LBPA+ vesicles were observed (Fig. 6A, 
6C). The number of LBPA+ vesicles was reduced in non-stimulated cells expressing GFP-DGKα (Fig. 
6A); this effect was dramatic upon CCh stimulation (Fig. 6A and 6C).  
With regards to the effect of DGKα on the traffic of CD63-containing vesicles, the analysis of 
CD63 relocation at the PM induced by CCh stimulation showed no differences between GFP-DGKα+ 
and GFP-DGKα- cells (Fig 6B, top panels) at several time points; the same result was observed in 
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VPS4EQ+ cells (Fig. 6B, lower panels). Thus, the expression of DGKα  or VPS4EQ seemed not to affect 
the transport, docking and fusion of the CD63+ vesicles to the PM in a non-polarized model of secretion.   
The recognition of target cells by CTLs induces polarization of MVBs towards the immune 
synapse, and the polarized transport, docking and fusion of MVBs with the PM at the synapse2. 
Therefore, the accumulation of CD63 at the PM in a synapse model provided information to extend the 
findings regarding the role of DGKα on secretion to a polarized situation. To perform these experiments 
we used Raji cells presenting Staphylococcal Enterotoxin E (SEE) to Jurkat cells24 expressing GFP-
CD63. As seen in Suppl. Fig. S6 recorded 5 h after synapse formation, there was an accumulation of 
GFP-CD63+ vesicles close to the synapse; the movement of vesicles in and out from this area was 
recorded (video 5, video 6, Suppl. Fig. S6). In addition, an accumulation of GFP-CD63 in the cell surface 
was observed. We verified that overexpression of DGKα inhibited, and the inhibition of DGKα 
increased, the secretion of exosomes in the synapse (Fig. 7), as seen in the non-polarized model (compare 
Fig. 7 with Figs. 4C and 5A). Subsequently, we tested that R59949 specifically reverted the inhibition on 
exosome secretion exerted by DGKα, but not DGKζ, since the inhibitor partially rescued the inhibitory 
effect of DGKα  on exosome secretion, but not the corresponding to DGKζ  (Fig. 7).  
The absence of DGKα  inhibits the polarized traffic of MVBs 
Since it is possible that the absence of DGKα may exert a different effect on secretion when 
compared with the inhibition of the kinase activity of DGKα, we analysed polarized traffic and secretion 
in cells lacking DGKα. As seen in Fig. 8A, pSuper-SiRNA humanDGKα plasmid reduced the amount of 
DGKα protein when compared with non-relevant plasmids (Fig. 8A). This seemingly low reduction was 
more pronounced when DGKα was analysed in selected GFP+ cells (Fig. 9B). The interference on 
DGKα inhibited the polarized secretion of GFP-CD63+ exosomes induced by SEE (Fig. 8B, C). We 
aimed to reveal traffic events underlying the effect of DGKα interference on secretion. Thus, we 
analysed the relocation of endogenous CD63 to the synapse, which is consequence of the degranulation 
of MVBs2. As seen in Fig. 9A, upon stimulation with SEE for 1h or 5h, the interfered GFP+ cells had 
low levels of cell surface CD63 when compared to GFP- cells, as assessed by flowcytometry (Fig. 9A, 
lower panel). The absence of DGKα did not affect the formation of mature MVBs since the number of 
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MVBs per cell remained unchanged (Fig. 9B). Since degranulation of MVBs was inhibited in the 
absence of DGKα, but both the formation of synapses and number of MVBs remained unaffected, we 
analysed the ability of cells DGKα− to polarize MVBs. To this end, we labelled DGKα, together with 
intracellular CD63 or LBPA. As seen in Fig. 9B, GFP+ cells lacking DGKα and stimulated for 1 h or 5 h 
were unable to polarize CD63+ or LBPA+ granules (not shown) towards the synapse, when compared to 
GFP-DGKα+ or GFP+DGKα+ cells. Therefore, most probably, an inhibition of polarization of mature 
MVBs towards the synapse underlied the effect of DGKα interference on secretion of exosomes. 
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DISCUSSION 
Our data support that T lymphocyte activation increases the number of mature MVBs that contain 
FasL on their ILVs. Besides this effect of cell activation on formation of mature MVBs, an increase in 
mobilisation, docking and fusion of these MVBs to the PM may underlie the stimulated release of FasL-
bearing exosomes. The inhibition of DGKα kinase activity, previously shown to enhance exosome 
secretion8, also increases the formation of mature MVBs induced upon activation. However, we could not 
rule out a non-specific effect of the inhibitor. Thus, we tested that the inhibitor acted on DGKα, but not 
on DGKζ, since the inhibitor did not rescue DGKζ-induced inhibition of exosome secretion (Fig. 7). To 
examine a possible negative function of DGKα kinase activity in the transport, docking and fusion of 
MVBs with the PM, we overexpressed DGKα and analysed these events. We observed that DGKα 
negatively regulated the formation of mature MVBs, but did not appear to affect their subsequent traffic. 
In contrast, the association of DGKα with MVBs, the effect of DGKα on the formation of mature MVBs, 
the association of DGKα with exosomes, and its role on exosome secretion, are compatible with the idea 
that DGKα kinase activity is an important negative regulator of the formation of MVBs. The fact that 
inhibition of DGKα kinase enhances the number of mature MVBs and partially rescues the inhibition of 
exosome secretion conferred by DGKα overexpression, supports the notion of DGKα  kinase activity act 
as an important negative regulator of polarized and non-polarized exosome release. In addition to the 
positive effect of the inhibitor on the inducible secretion, we observed also a positive effect on the 
constitutive secretion of exosomes (Figs. 3A and 5A)8. It is known that there is constitutive DAG 
production at intracellular membranes25. This DAG pool is necessary for constitutive vesicular traffic15, 
and R59949 has been shown to enhance basal DAG levels on endomembranes25, probably by inhibition 
of DGKs. Thus, it is conceivable that the inhibitor -by affecting intracellular DAG pools- may positively 
control the constitutive traffic of MVBs, and subsequently, the basal secretion of exosomes.  
We investigated the role of DGKα in the polarized secretion of exosomes. By using an interference 
approach on a synapse model, we uncovered a positive role of DGKα on exosome secretion. In 
DGKα−interfered cells, polarization of MVBs and subsequent exosome release were reduced (Fig. 9). 
This, together with the fact that the kinase inhibitor increases polarized secretion of exosomes (Fig. 7) 
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implies that some non-kinase function of DGKα is required for polarized secretion. The fact that R59949 
partially rescues the negative effect of DGKα overexpression on exosome secretion (Fig. 7), together the 
inhibitory effect that DGKα downmodulation produces on MVBs polarization and degranulation (Figs. 
8, 9), suggest that different functional domains of DGKα negatively and positively control the secretory 
traffic of exosomes at, at least, two distinct regulatory points. Whereas the kinase domain appears to be 
negatively involved in formation of mature MVBs, other(s) domain(s) would be positively involved in 
MVBs polarization. Although both the nature of these domains and their effectors remain unknown, our 
results point out to a complex, fine-tuned control of the secretory traffic of exosomes exerted by DGKα.   
The lipid composition of vesicles constitutes a factor in the maturation of MVBs that is susceptible 
to regulation by DGKα. The contribution of LBPA has interest, since LBPA provides negative curvature 
to the MVB limiting membrane during the inward invagination to form the ILVs26. In the latter study, it 
has been shown that ALIX, a protein that interacts with ESCRT complexes, binds to LBPA-containing 
liposomes. When ALIX levels were down-regulated, the formation of LBPA-containing endosomes 
decreased26. Thus, ALIX regulates the maturation of MVBs. LBPA is locally produced in MVBs26, but 
the steps involved in LBPA synthesis remain unclear. Therefore, it will be interesting to analyse the 
consequences of the regulation of DAG levels by DGKα on both the synthesis of LBPA and the 
recruitment of ALIX/ESCRT to the MVBs. One possibility that may explain the inhibition of exosome 
secretion by DGKα and the fact that DGKα overexpression inhibits the formation of LBPA+ vesicles is 
that the enzyme would affect the maturation (number of ILVs) of MVBs. If this is the case, then DGKα 
could be found associated with the MVBs and secreted in exosomes, as we have shown. Thus, quite 
probably, DGKα controls the inward budding in MVBs.  The changes induced by R59949 in the 
distribution of CD63 on gradients (Fig. 3B) support this hypothesis, since the maturation of late 
endosomes/MVBs is associated with an increase in their content in LBPA, which confers a shift in the 
density of MVBs27.  
Apart from this potential role of DGKα on the lipid composition of MVBs, it is conceivable that 
DGKα activity may affect the gradient of DAG at the synapse, this gradient is crucial for MTOC 
polarization in CTLs17. DGKα relocates to the PM upon cell activation and regulates the intensity of 
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signalling of DAG-controlled pathways in T lymphocytes11, thus it is conceivable that DGKα may 
contribute to maintain a DAG gradient at the synapse. Loss of this gradient as a result of DGKα 
downregulation could be responsible for the defect in MVBs polarization and degranulation. However, 
our data showing that R59949 increases polarized secretion of exosomes rules out that the inhibition of 
polarized secretion in DGKα-interfered cells may be due to the absence of DGKα kinase activity, that 
would otherwise control a DAG gradient at the PM. Our results describing an increment in exosome 
secretion by treatment with R59949 are in apparent contradiction with the studies by Quann et al.17, 
showing that DGK kinase activity is required to maintain a stable DAG gradient. Treatment of CTLs 
with R59949 induced a defect in the persistence of both MTOC polarization and the secretion of cytolytic 
factors towards the synapse and CTL-mediated killing17. The divergence may be due to the fact that 
mouse CTLs, instead of human cell lines, were used in that study17; and no evaluation of the secretion of 
exosomes and their contribution to apoptosis was performed. In addition, in DGKα–overexpressing cells 
the secretion of exosomes is reduced, and there are few CD63+/LBPA+ vesicles per cell. However, the 
MVBs are transported, dock, and fuse normally with the PM in cells overexpressing DGKα. Thus, the 
inhibition of the formation of mature MVBs appears to be the limiting step in secretory traffic of 
exosomes, at least in cells overexpressing DGKα. Since GFP-DGKα translocates to the PM, it is 
conceivable that the gradient of DAG at the synapse that may control MVBs polarization17 is maintained 
in these cells. In contrast, in DGKα-interfered cells the defective polarization of MVBs would constitute 
a different, limiting step for exosome secretion. Experiments involving the use of  “caged” 
dioctanoylglycerol (DOG)17 photoactivable at different locations (synapse, MVBs), and the expression of 
DAG sensors such as C1 domains of PKCθ fused to GFP28,25 may help to evaluate spatio-temporal 
changes of DAG levels, both in DGKα-overexpressing and DGKα-interfered cells, and to study the 
consequences of these changes on traffic of MVBs and exosome secretion.  
Taken together, our data support the idea that the combination of positive signals triggered by 
receptor stimulation and a fine-tuning effect of a negative regulator, i.e. the kinase activity of DGKα, 
control the secretory vesicle pathway that is responsible of the secretion of exosomes. The negative effect 
of DGKα kinase activity on traffic was exerted at the stage of formation of mature MVBs. In addition, a 
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non-kinase function of DGKα is necessary for polarization of MVBs and exosome secretion. These 
inferences may conciliate the DGKα interference data with the fact that R59949 kinase inhibitor 
enhances polarized secretion and rescues the negative effect of DGKα overexpression on exosome 
secretion. Thus, DGKα appears to coordinate both positive and negative signals that are exerted at two 
different stages of the traffic of MVBs; the balance of these signals seems to be crucial for exosome 
secretion.   
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MATERIAL AND METHODS 
Cell cultures  
J-HM1-2.2 cells expressing human muscarinic type 1 receptor (HM1R) have been described 
29; these cells stimulated with agonist carbachol have been widely used as an appropriate model to 
induce full activation signals 11 and AICD 13.  Raji B cell line was from ATCC. 
Antibodies and reagents 
The anti-DGKα antibody (Ab) for WB and  immunofluorescence was from Abnova (Taiwan). 
Anti-Fas Ligand (CD95L) NOK-1 mAb, Lamp-1 (clone 25), anti-CD3 (UCHT1) and anti-Fas Ligand 
G247-4 for immunofluorescence were obtained from BD Biosciences and Santa-Cruz Biotechnology. 
Rabbit polyclonal anti-Fas Ligand (CD95L) Q-20 for Western blot (WB) was from Santa Cruz 
Biotechnology. Anti-CD63 (clone NKI-C-3) was from Oncogene. Anti-Golgi 58K protein (clone 
58K-9) was from SIGMA. Anti-lysobisphosphatidic acid (LBPA) Ab 6C4 was a kind gift from Dr. J. 
Gruenberg. All horseradish peroxidase-coupled secondary antibodies were from Dako. Carbachol 
(CCh) was from SIGMA. The DGK inhibitor II (R59949) was purchased from Calbiochem. This 
inhibitor is specific for the type I DGK isotypes (as DGKα) but does not inhibit DGKζ10,21(the other 
DGK isotype expressed in T lymphocytes30). Alexa Fluor-coupled secondary antibodies were from 
Invitrogen. Staphylococcal Enterotoxin E (SEE) was from Toxin Technology, Inc (USA). Cell tracker 
blue (CMAC) was from Invitrogen. 
Expression vectors, siRNA interference vectors and transfection assays 
The plasmids pEFbos-GFP, pEFGFP-DGKα, pEFGFP-DGKζ have been described 8,11,30. pEFGFP-
C1bosCD63 and pECFP-C1CD63 were a generous gift from Dr. G. Griffiths. pDsRed2-CD63 was 
prepared by subcloning cDNA corresponding to human CD63 from pEFGFP-C1bosCD63 into 
pDsRed2-C1 vector (BD Biosciences). Expression vectors for GFP-VPS4wt and GFP-VPS4EQ 
mutant were a gift from Dr. P. Whitley 31. siRNAs expression was achieved by using pSUPER RNAi 
System (pSR-GFP bicistronic or pSuper plasmids) (Oligoengine). One sequence of human 
DGKα isoform was selected to generate 64 bp double-strand DNA oligonucleotides encompassing the 
19-nucleotide interfering sequence 5’-GCCAGAAGACCATGGATGA-3’ and a hairpin-forming 
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sequence, which were cloned in these plasmids. Equivalent sequence 5’-
ACACAAGACCACAGATGAT-3’ (mouse DGKα) or 5’-CTATGTGACTGAGATCGCA-3’ (human 
DGKζ) isoform were used in negative control plasmids. For transfection experiments, cells were 
transiently transfected with 20-30 µg of the plasmids as described 32. Expression vectors for DGKs or 
siRNAs vectors were cotransfected in Jurkat cells in molar excess (3:1) to exosome reporters (GFP-
CD63). 
Isolation of exosomes  
The exosomes produced by equal number of cells for each experimental condition were 
isolated from the cell culture supernatants as previously described 6,7. Using these standard protocols, 
culture supernatants of 20x106 cells were centrifuged at low speed in sequential steps and then 
clarified to eliminate cells and cell debris. To obtain the exosomes from cells expressing the exosome 
reporters GFP-CD81, GFP-CD63 and DsRed2-CD63 a similar protocol was performed, although 
1x106 effector cells (Jurkat) were used. For the secretion of exosomes in immune synapse 
experiments, expression vectors for DGKs or siRNAs vectors were cotransfected in Jurkat cells in 
molar excess (3:1) to exosome reporter vectors (i.e. GFP-CD63), and the formation of synapses with 
Raji cells in the absence (control) or presence of superantigen (SEE) was performed 2-3 days after 
transfection as described below. The exosomes were recovered by ultracentrifugation (100.000xg for 
12 h) as described 6, and resuspended in 50 µl of RIPA lysis buffer, or directly quantified by flow 
cytometry (see below). We usually loaded 25 µl of this lysate per lane for WB analysis. We 
commonly obtained between 50-150 µg of protein in the 100000xg pellet from 20x106 CCh-
stimulated cells. In the experiments that involved the isolation of exosomes and WB, each lane of the 
blot contained the total protein that was recovered in the culture medium from the same number of 
cells, untreated or treated with stimuli in the presence or in the absence of DGK inhibitor. The lysates 
of the cells recovered after the first step of the protocol for exosome isolation were run in parallel to 
the exosomes, to internally normalise WBs by viable cell number at the end of the culture period for 
exosome secretion, but also to normalise transfection efficiency of the XFP-CD63 reporter. 
Alternatively, the number of exosomes in the clarified culture supernatants was quantified by flow 
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cytometry, using a constant acquisition period (5 min) and calibration fluorescent beads (50 and 100 
nm beads, from SIGMA).  Forward and side scatter light detectors together with gating regions, were 
set up to detect properly the calibration beads, and the absolute number of gated events equal to 
number of exosomes was represented using dot plot (forward versus side scatter) analysis. In parallel, 
samples corresponding to complete medium including the different reagents, but in the absence of 
cells, were analysed, and these dot plots registered a constant number of events; thus events above this 
background were considered as specific, cell-produced vesicles.  
Western blot analysis 
Cells and exosomes were lysed for 10 min in RIPA buffer containing protease inhibitors, and 
the proteins separated by SDS-PAGE under reducing conditions and transferred to HybondTM ECLTM 
membranes (GE Healthcare). For CD63 detection, proteins were separated under non-reducing 
conditions as described 8. After incubation with the appropriate primary antibody, the blots were 
developed with HRP-conjugated secondary antibodies using enhanced chemiluminescence (ECL) 
reagents and following standard protocols. 
Cell fractionation  
J-HM1-2.2 cells were disrupted in 2 ml of an iso-osmotic homogenization buffer 2 and the 
homogenate was fractionated on a discontinuous Percoll (Amersham Pharmacia) gradient as described 
2,8. The subcellular fractions from the same number of control and stimulated cells were analysed in 
parallel for the presence of CD63, FasL, DGKα and Lamp-1 proteins by WB. Lamp-1 was used as an 
appropriate, internal loading control. Density was calibrated using density marker beads (Amersham 
Pharmacia).  
Electron microscopy 
 JHM1-2.2 cells were fixed for 20 min at RT in 2% PFA/1.5% glutaraldehyde in 0.1 M sodium 
cacodylate, pH 7.4. Cells were washed twice in 0.1 M sodium cacodylate and were spun into a tight 
pellet for osmication with 1.5% potassium ferricyanide, 1% osmium for 1 h at 4º C. The cell pellet was 
washed several times with 0.1 M sodium cacodylate and incubated with 1% tannic acid in 0.05 M 
sodium cacodylate for 45 min at room temperature. The cell pellet was rinsed in 1% sodium sulphate 
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in 0.05 M sodium cacodylate for 5 min and with dH2O for 3 min. The cell pellet was dehydrated 
stepwise in ethanol (70%-90%-absolute ethanol). Ethanol was removed and propylene oxide was 
added for 2 x10 min and the cell pellet was embedded in 1:1 mixture of epon and propylene oxide. 60-
70 nm ultra-thin sections were cut on an ultramicrotome, collected onto grids and examined with a 
Philips EM420 transmission electron microscope. 
Immunofluorescence analysis 
 
For fluorescence analysis of living J-HM1-2.2 cells expressing the different constructions, 
cells were attached to glass-bottom 35 mm culture dishes (Mat-Tek) using fibronectin at 24-48 h post-
transfection, and stimulated in culture medium without phenol red at 37 ºC 32. In some experiments, 
immune synapses between GFP-CD63 expressing Jurkat cells and Raji B cells pulsed with 
superantigen SEE and labelled with CMAC were performed as previously described 24. Subsequently, 
epifluorescence images were taken with a Nikon Eclipse TE2000S microscope equipped with a DS-
5M digital camera and a Plan Apo VC 60x NA 1.4. objective. Time lapse analysis was performed in 
living cells using ACT2-U software or NIS-AR software (NIKON). After the culture period, samples 
were either cell-surface stained or fixed and stained as described 32 with primary Abs (anti-CD63, 
anti-LBPA, anti-DGKα, anti-FasL) and appropriate secondary Alexa Fluor-conjugated Abs 
(Invitrogen). Confocal microscopy was performed using a Bio-Rad Radiance 2100 scan head mounted 
on a Nikon ECLIPSE TE 2000U microscope and using 60x NA 1.4 PlanApo objective. No labelling 
was observed when using the secondary Abs alone. Z-axis projection (maximun intensity) and merged 
images for colocalization experiments were performed using ImageJ software. For quantification, 
digital images were analysed using EasiVision SIS image analysis software (Soft Imaging Software, 
Munster, Germany) and ImageJ software (Rasband, W.S., ImageJ, National Institutes of Health, 
Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2004). Experimental significance of the 
results obtained at the single cell level was achieved by analysing a minimal number of 60 cells 
(unless otherwise indicated) from different microscope fields, and a minimal number of 3 independent 
experiments. Results were expressed as average minus/plus standard deviation (SD), and correspond 
to the means of the separate experiments, and not to the pooled cells measured together. ANOVA 
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analysis was perfomed for statistical significance of all the results. Trajectories of vesicles in videos 
were plotted by using NIS-AR software (NIKON). Epifluorescence image improvement was achieved 
by using deconvolution software (Huyghens, SVI). 
Flow cytometry 
After the indicated culture periods, cells were fixed and intracellularly stained with no Ab 
(negative controls) or primary Abs (anti-CD63, anti-LBPA, anti-FasL) and appropriate secondary, PE 
or FITC-conjugated Abs (Becton Dickinson). A minimal number of 10000 cells were analysed for 
FL-1 or FL-2 fluorescence by using FACSCAN flow cytometer (Becton Dickinson). For the 
experiments involving analysis of cell surface CD63 on Jurkat cells after synapse formation, Raji cells 
preloaded with CMAC were excluded from the flow cytometry analysis by electronic gating of 
CMAC-negative cells, and comparison of the CD63 red fluorescence on both Jurkat GFP- and GFP+ 
cells was performed using a FACS-Vantage flow cytometer equipped with an UV excitation laser. 
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FIGURE LEGENDS 
Fig. 1. Cellular stimulation induces the formation of mature MVBs. A) Upper panel, J-HM1-2.2 cells 
were stimulated with CCh for 6 h and then were imaged by confocal microscopy using antibodies specific 
for CD63, FasL, and LBPA. Lamp-1 is mostly present on the limiting membrane of MVBs, whereas 
CD63, and particularly LBPA, are abundant in the ILVs 27 and therefore label mature MVBs. LBPA is a 
phospholipid that participates in the maturation of MVBs 33 and constitutes a bona fide marker for ILVs 
of mature MVBs 33.  Z- axis projections for each antigen corresponding to representative cells from 3 
independent experiments are represented. Lower panel, quantitative analysis of vesicles. Vesicle numbers 
were recorded from at least 20 cells per group, chosen randomly as indicated in Material and Methods. 
Results represent average number of vesicles/cell + SD of 3 independent experiments. B) J-HM1-2.2 cells 
transfected with CFP-CD63 were stimulated with CCh (for 6 and 16 h), and mature MVBs were 
visualised with anti-LBPA antibody (red) as indicated in Material and Methods. Cells were imaged by 
confocal microscopy and representative (n=3 independent experiments), single optical sections (0.4 µm 
thick) and merged images (coincident labelling appearing pink) are shown in the right side. In the left 
side, Z-projection images of LBPA and CFP-CD63 are shown.  
Fig. 2. Cellular stimulation induces the relocalisation of Fas ligand and DGKα  to subcellular 
fractions containing MVBs. Cellular fractionation by density gradient of the homogenates from equal 
numbers of J-HM1-2.2 cells, stimulated or not with CCh (6 hours), was performed as indicated in 
Material and Methods, and the Percoll fractions were analysed for CD63, DGKα, and FasL by WB. The 
blot was reprobed with anti Lamp-1 Ab as a loading control. Data are representative of the results 
obtained in 3 different experiments. 
Fig. 3. Inhibition of DGKα  kinase activity increases the number of MVBs and the secretion of 
exosomes. (A) The secretion of exosomes was induced by treatment of J-HM1-2.2 cells with CCh during 
10 h, preincubated or not with R59949 (10 µM). In the upper row, the dot plots correspond to the events 
recorded – the number of events is included inside each plot - in the cell culture supernatants from cells 
treated as indicated, whereas the lower row plots register the events from complete medium treated with 
the different reagents but in the absence of cells. The lower row dot plots registered a constant number of 
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events; thus events above this background should be considered as specific, cell-produced vesicles. In the 
right-hand side, dot plots corresponding to 50 nm and 100 nm latex beads analysed in parallel are 
included as a reference. (B) WB with anti-CD63 of Percoll density gradient fractions from cells 
stimulated with CCh for 6 h, pretreated or not with R59949. Data are representative of the results 
obtained in 3 different experiments. The shift in the distribution of CD63 on the density gradient is 
compatible with changes in the lipid composition and the maturation of MVBs 27. 
Fig. 4. DGKα  is associated to CD63+ vesicles and exosomes. A) Cells expressing GFP-DGKα were 
stimulated with CCh for 6 h in the presence of R59949, stained with anti-CD63 (red) and cells were 
imaged by confocal microscopy; several representative, optical sections (0.4 µm thick) are shown. The 
right-hand panels show the merged images, with coincident labelling appearing yellow. B) Digital zoom 
(1.67x) of some images from one experiment similar to that described in panel A are shown. C) 
Cells were stimulated or not with CCh (50 and 500 µM) for 12 h in the presence or absence of R59949 
(10 µM), and the secreted exosomes were analysed by WB for the presence of several exosome markers 
and endogenous DGKα. Results are representative of the data obtained in 3 different experiments. 
Fig. 5. Expression of the reporters for MVBs/exosomes in living cells. A) J-HM1-2.2 cells expressing 
DsRed2-CD63 (upper panels) or GFP-CD63 (lower panels) were stimulated with CCh for 10 h in the 
presence or the absence of R59949 inhibitor (R59, 10 µM), and the isolated exosomes were analysed by 
WB with anti-CD63 to detect the chimerical CD63 molecules. Different exposures of the same blot are 
shown to visualize both the chimeras and the endogenous CD63. In the right side lanes of each blot, 
lysates from cells expressing or not the CD63 chimeras were run as a reference. B) Cells expressing 
GFP-CD63 were stimulated or not with CCh for 6 and 24 h in the presence or the absence of R59949, in 
order to visualize the formation and fate of MVBs in living cells. The CCh and R59949-induced increase 
in GFP-CD63 at the plasma membrane, was probably due to the fusion of the limiting membrane of GFP-
CD63+ MVBs (See also Supplementary Material, videos 3 and 4). The epifluorescence images were 
improved by image deconvolution as indicated in Material and Methods, and are representative of the 
results obtained in more of 50 cells recorded per treatment in 4 independent experiments. The inset 
shows a 2X digital zoom of the indicated area.  
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Fig. 6. Expression of GFP-DGKα  affects the formation of mature MVBs and the distribution of 
LBPA+ vesicles, but does not inhibit the accumulation of CD63 at the plasma membrane. Jurkat 
cells expressing GFP-VPSwt, GFP-VPS4EQ mutant or GFP-DGKα, together with CFP-CD63, were 
stimulated with CCh to induce the formation and traffic of MVBs, and LBPA was stained as indicated in 
Material and Methods. The ESCRT (Endosomal Sorting Complex Required for Transport) machinery is 
involved in the formation of the intraluminal vesicles of MVBs and the AAA-ATPase vacuolar protein 
sorting VPS4 regulates the recycling of the ESCRT complexes 34. The expression of a VPS4 ATPase-
defective mutant, VPS4EQ, inhibits the inward budding at the limiting membrane of MVBs and the 
subsequent formation of ILVs 22,35. These effects result in the formation of immature, large endosomes 
22,23, and thus the expression of VPS4EQ mutant constitutes an appropriate control for aberrant MVBs 
maturation.  A) Epifluorescence microscopy images (GFP-X, CFP-CD63, and LBPA, respectively) of 
control and CCh-stimulated (8 h) cells. In GFP-VPS4EQ-expressing cells the dispersion of LBPA+ 
granules that was induced by CCh in GFP-VPS4EQ- cells or in cells expressing GFP-VPS4wt was 
inhibited, and the large LBPA+ structures accumulated in the perinuclear area.  B) Cells expressing GFP-
DGKα  (upper rows) or GFP-VPS4EQ (lower rows), together with CFP-CD63 were stimulated with CCh 
for the indicated times to visualize the accumulation of CFP-CD63 at the plasma membrane by 
fluorescence microscopy. CD63 cell surface labelling is a consequence of the transport, docking and 
fusion of MVBs with the plasma membrane (See also Fig. 5B, Supplementary Videos 3 and 4). C) The 
average number per cell and the mean diameter (+SD) of LBPA+ vesicles were measured in cells from 3 
independent experiments similar to that described in panel A (in a total of 11 control, untransfected cells, 
8 GFP-DGKα+ cells, and 19 GFP-VPS4EQ+ cells) after 6 h of CCh stimulation. In a significant fraction 
(40-50%, n=20 cells) of GFP-DGKα-expressing cells the number of LBPA+ vesicles was lower to that 
found in GFP-DGKα- cells stimulated with CCh (Suppl. Fig. S5, panel A, third row). In approximately 
20% of GFP-DGKα+ cells, the LBPA+ structures were condensed in some areas but not dispersed 
throughout the cytosol (Suppl. Fig. S5, panel A, lower row), as observed in GFP-VPS4EQ+ cells (Suppl. 
Fig. S5, panel A, second row). See also Supplementary Fig. S5, panel C. 
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Fig. 7. Modulation of DGKα  pathway controls the polarized secretion of exosomes. Jurkat cells 
coexpressing GFP-DGKα or GFP, together with GFP-CD63 were mixed with Raji cells, pulsed or not 
with SEE, to induce the formation of synapse and the secretion of exosomes. Upper panel: the amount of 
exosomes produced by cells expressing similar amounts of GFP-CD63 (cell lysates, right side) at the end 
of the culture period was measured by WB with an antibody against CD63. Middle panel: Quantification 
of the secretion of exosomes in cells expressing GFP-DGKα in comparison to cells expressing GFP. 
Results summarize the data obtained from WB in 4 independent experiments and are represented as 
average (+SD) fold induction of exosome secretion. Lower panel: the effect on exosome secretion of the 
pretreatment with R59949 (10 µM) of cells expressing GFP (control), GFP-DGKα, or GFP-DGKζ   was 
measured as indicated in the middle panel (n=3 independent experiments).  
Fig. 8. Interference of DGKα  inhibits polarized exosome secretion. Jurkat cells were cotransfected 
with interference plasmids for human DGKα, human DGKζ, or an irrelevant, mouse DGKα, together 
with reporter GFP-CD63, and were stimulated with Raji cells, pulsed or not (control) with SEE, to induce 
secretion of exosomes. Transfection efficiency of Jurkat cells in these experiments was around 50%, as 
assessed by flow cytometry. A) WB of Jurkat cells transfected with the interference plasmids before 
stimulation with Raji cells, showing the specificity of the interference with specific antibodies against 
DGKα and DGKζ. B) WB of the exosomes (upper panel) isolated from the cell culture supernatants of 
the interfered cells after synapse formation (12 h). In the right side, extracts of cells transfected with an 
empty vector and a GFP-CD63 vector were analysed as reference. The WB of the cells (lower panel) 
recovered after the culture period was performed in parallel to normalise by viable cell number at the end 
of the culture period and by transfection efficiency of the GFP-CD63 reporter. C) Summary of the results 
from 4 independent experiments similar to the one shown in panel B; results are represented as average 
(+SD) percent of SEE induction of exosome secretion. 
Fig. 9. Interference of DGKα  affects polarization and degranulation of MVBs at the immune 
synapse. Jurkat cells transfected with a GFP-containing, bicistronic interference plasmid for human 
DGKα were stimulated for 1 and 5 h with Raji cells previously pulsed with SEE and labelled with 
CMAC (blue), to induce synapse formation and the polarized traffic of MVBs. A) Upper panel: 
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Degranulation of MVBs at the synapse after 5 h was assessed by cell surface staining of endogenous 
CD63 (orange-red) and fluorescence microscopy. White arrowheads label the synaptic contact areas 
made by GFP- Jurkat cells, whereas green arrowhead labels the synapse corresponding to a GFP+ Jurkat 
cell. Images are representative of the results obtained in 4 different experiments. Lower panel: 
Degranulation induced by SEE was measured after 1 and 5 h, by analysing cell surface staining of CD63 
in both GFP+ (DGKα-) and GFP–(DGKα+) Jurkat cells by flow cytometry. The FACS profiles 
corresponding to the staining of Jurkat cells challenged with Raji without SEE are not shown for clarity, 
but the corresponding MFI (Mean Fluorescence Intensity) data are included (Control). B) Upper panel: 
Quantification of LBPA+ and CD63+ intracellular vesicles in Jurkat cells forming synapse with SEE-
pulsed Raji cells during 5 hours. Middle panel: polarization of MVBs towards the synapse after 5 h was 
assessed by intracellular labelling of endogenous CD63 (orange-red). Interference with DGKα 
expression was tested by intracellular staining of endogenous DGKα (red). White arrowheads label 
synapses made by GFP- DGKα+ Jurkat cells, whereas green arrowhead labels the synapse corresponding 
to a GFP+ DGKα− Jurkat cell. Images are representative of the results obtained in 4 different experiments. 
The insets shows a 2x digital zoom of the indicated areas. Lower panel: the graph summarizes the results 
of 4 independent experiments (at least 40 cells per condition were analysed) similar to the one described 
in the middle panel, and compares the percentage of cells with polarized MVBs after 1 and 5 h of 
stimulation, both in DGKα+ cells and DGKα- cells. Cells with polarized MVBs were defined as those 
cells on which the majority of their MVBs located at a distance of the synapse lower than one quarter of 
the diameter of the cell. The interference on DGKα expression does not affect the interaction among T 
lymphocytes and the SEE-presenting cells, since the frequency of formation of Raji/Jurkat conjugates 
was not affected by DGKα interference (not shown). 
 
LEGENDS FOR ONLINE SUPPLEMENTAL MATERIAL 
Videos 1 and 2  
J-HM1-2.2 cells expressing CFP-CD63 were either left untreated (Video 1) or stimulated with CCh for 
24 h (Video 2). After this period, videos were captured at 8 frames per second and a frame size of 
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640x480 pixels using a Nikon DS-5M camera. The videos were edited using ImageJ and VirtualDub 
software. The final frame display rate is 6 frames per second. Blue represents the chimerical CFP-CD63 
molecule. 
 
Videos 3 and 4 
J-HM1-2.2 cells expressing GFP-CD63 were stimulated with CCh for 3 h (Video 3) or 6 h (Video 4). 
Videos were captured and processed as previously indicated; green represents GFP-CD63. In video 3, the 
movement of a GFP-CD63+ vesicle towards the plasma membrane and its disappearance in proximity to 
the membrane can be observed in the lower part of the cell located in the left side. This extinction event 
took place concomitantly to a transient increase in fluorescence at the docking site at the cell surface 
(Video 3), which may be due to the fusion of a GFP-CD63-containing vesicle with the PM. In video 4, 
the extinction of a ring-shaped, GFP-CD63-decorated vesicle can be observed in the right side of the cell.  
Video 5  
Raji B cells labelled with cell tracker blue (CMAC, blue) were pulsed with SEE for 30 min and synapses 
with Jurkat cells expressing GFP-CD63 were formed as indicated in Material and Methods. 4 hours after 
synapse formation, videos corresponding to GFP-CD63 were captured (7 frames per second) and a 
representative example out of 47 synapses recorded is shown. See also Supplementary Fig. S6 to 
visualize CMAC fluorescence corresponding to this experiment. 
Video 6 
Same as video 5, but the formation of a double synapse between one Jurkat cell and two Raji cells 
(CMAC, blue) was recorded from the beginning (10 frames per second). Simultaneous capture of GFP-
CD63 and CMAC fluorescence was performed using NIS-AR software. Deconvolution of the GFP-CD63 
fluorescence channel was performed as indicated in Material and Methods. A representative example out 
of 11 synapses recorded is shown. 
 
Supplementary Fig. S1.  J-HM1-2.2 cells were stimulated with CCh or not (Control) for the indicated 
times, stained with anti-CD63, anti-FasL, or anti-LBPA, and the fluorescence (Mean Fluorescence 
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Intensity, MFI) measured by flow cytometry. Negative samples (Neg) correspond to cells stained only 
with secondary antibody. In the inset from the middle panel, a WB of cell extracts developed with anti-
FasL (Q-20 Ab) is shown. 
 
Supplementary Fig. S2. Quantitation of LBPA+ CD63+ vesicles and statistical analysis of the results 
obtained in similar experiments to that represented in Fig. 1B was performed as described in Material and 
Methods, in cells stimulated or not (control) with CCH (6 and 16 h). Results are represented as average 
number (+SD) of vesicles per cell and summarize the results obtained in 4 independent experiments. 
 
Supplementary Fig. S3. Electron microscopy of MVBs. J-HM1-2.2 cells were stimulated with CCh for 
8 hours in the presence or the absence of R59949 and processed for electron microscopy as indicated in 
Material and Methods. Representative sections of the results obtained with at least 30 different cells are 
shown. Black arrowheads label vesicles resembling MVBs. Some enlarged areas (insets 1 to 4) showed 
the presence of electron-dense ILVs inside MVBs. KEY: n; nucleus; M; mitochondria; G; Golgi. Lower 
panel: the mean number (+SD) of MVBs per cell is represented. Quantitation was performed by counting 
vesicles on randomly chosen sections, and summarize the results from 4 different experiments. 
 
Supplementary Fig. S4. Cells pretreated or not with R59949 (10 µM) were stimulated with CCh for 6 h. 
Left panel: confocal microscopy of cells after CD63 and LBPA labelling (Z-projections). Representative 
images of the results obtained in 3 independent experiments are shown. Right panels: quantitation of the 
number of CD63+ and LBPA+ vesicles. Results are represented as average numbers (+ SD) of 
vesicles/cell from 40 cells analysed in 3 independent experiments. R59949 alone had no effect on the 
number of CD63+ or LBPA+ intracellular vesicles.  
 
Supplementary Fig. S5. A) Cells were transfected with different GFP fusion constructs (GFP-VPS4wt, 
GFP-VPS4EQ and GFP-DGKα), stimulated with CCh (8 h) and stained with anti-LBPA, and imaged by 
confocal microscopy. Z-projection images of the GFP-containing construction and LBPA staining are 
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shown to visualize the effect of the different constructions on the subcellular distribution of LBPA. B) 
Cells expressing GFP-VPS4EQ mutant together with CFP-CD63, were stimulated for 8 h with CCh and 
stained with anti-LBPA (red) as indicated in Material and Methods. Cells were imaged by confocal 
microscopy and a representative, single optical section (0.4 µm thick) is shown in the upper row. The 
lower row shows the merged images, with coincident labelling appearing yellow, pink and sky blue, 
respectively. C) The vesicle diameter distribution analysis corresponding to the experiment summarized 
in Fig. 6C was performed as indicated in Material and Methods. The distribution is represented as a 
histogram of the average (+SD) vesicle number per cell versus the indicated vesicle diameter classes. 
Supplementary Fig. S6. Raji B cells labelled with CMAC (R) were pulsed with SEE and synapses 
with Jurkat cells expressing GFP-CD63 (J) were formed as indicated in Material and Methods. Four 
hours after synapse formation, snapshots (transmittance plus CMAC, GFP-CD63) and videos (GFP-
CD63, see Video 5 synapse) were recorded as indicated in Material and Methods. In the middle panel, 
the first frame corresponding to video 5 is shown, and one synapse area is seen at the upper left side of 
the Jurkat cell. In the right side panel, trajectories followed by GFP-CD63 vesicles from video 5 are 
plotted. 
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